Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.875 GBX | 0.00% | -10.26% | -45.31% |
Mar. 20 | Evgen Pharma Signs Takeover Deal with Chronos Therapeutics; Raises Capital Via Share Issue, Subscription | MT |
Mar. 19 | EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat | AN |
Financials (USD)
Sales 2024 * | 486K | Sales 2025 * | - | Capitalization | 3.04M |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | - | EV / Sales 2024 * | 1.76 x |
Net cash position 2024 * | 2.19M | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.7
x | P/E ratio 2025 * |
-
| Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.69% |
1 week | -10.26% | ||
Current month | -7.89% | ||
1 month | -16.67% | ||
3 months | -45.31% | ||
6 months | -58.33% | ||
Current year | -45.31% |
Managers | Title | Age | Since |
---|---|---|---|
Huw Jones
CEO | Chief Executive Officer | 62 | - |
Toni Haenninen
DFI | Director of Finance/CFO | - | 23-09-04 |
Glen Clack
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Huw Jones
CEO | Chief Executive Officer | 62 | - |
Susan Foden
CHM | Chairman | 71 | 14-11-20 |
Alan Barge
BRD | Director/Board Member | - | 15-10-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.875 | 0.00% | 116,116 |
24-03-27 | 0.875 | 0.00% | 1,185,440 |
24-03-26 | 0.875 | 0.00% | 2,281,489 |
24-03-25 | 0.875 | -7.89% | 2,359,794 |
24-03-22 | 0.95 | -2.56% | 1,417,725 |
Delayed Quote London S.E., March 28, 2024 at 12:35 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.31% | 3.04M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |